In the intricate landscape of medical cannabis, Belgium has established a regulated framework to govern the use of cannabis for medicinal purposes. Our insights stem from the comprehensive book “Principles of Clinical Cannabinology“ authored by Viola Brugnatelli and Fabio Turco, in collaboration with Cannabiscientia and Prohibition Partners.
This excerpt sheds light on the intricacies of medical cannabis regulation in Belgium, offering a glimpse into the thorough analysis and extensive information available in the book.
1. The Legal Framework: Royal Decree and Circular 648
Belgium’s foray into medical cannabis began with the Royal Decree of 11 June 2015, marking a significant step in regulating its usage.
Subsequently, Circular No. 648 was issued by the Federal Agency for Medicines and Health Products (FAMHP) on 16 July 2019, providing essential supplements to the original decree.